Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Hongyu Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1278-4183; OpenAlex author ID A5100341983. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 2 papers

Papers 9

  1. miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer. Co-author DOI 10.1080/15384047.2025.2457761↗
  2. Assessment of the reliability and quality of pancreatic cancer related short videos on mainstream platforms: cross-sectional study. Co-author DOI 10.1186/s12885-025-14825-2↗
  3. Research trends and hotspots of neoadjuvant therapy in pancreatic cancer: a bibliometric analysis based on the Web of Science Core Collection. Co-author DOI 10.1007/s10238-023-01013-4↗
  4. Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress. Co-author DOI 10.4240/wjgs.v15.i2.142↗
  5. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90. Co-author DOI 10.3390/cells11172756↗
  6. Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.652283↗
  7. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. Co-author DOI 10.1016/j.yexcr.2016.07.009↗
  8. Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.15786↗
  9. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells. Co-author DOI 10.1097/mpa.0b013e3182962acb↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jinzheng Li · 3 shared papers, 2023–2025 · strength 0.68
  2. Jun Gao · 4 shared papers, 2013–2025 · strength 0.45
  3. Yuqiong Wang · 3 shared papers, 2016–2025 · strength 0.42
  4. Jialun Peng · 1 shared paper, 2025 · strength 0.28
  5. Yan-fang Gong · 2 shared papers, 2013–2025 · strength 0.28
  6. Bing Qi · 1 shared paper, 2025 · strength 0.25
  7. Xiangyu Kong · 3 shared papers, 2013–2021 · strength 0.21
  8. Kun Fang · 1 shared paper, 2023 · strength 0.20
  9. Tao Liu · 1 shared paper, 2023 · strength 0.19
  10. Vignesh Vudatha · 1 shared paper, 2022 · strength 0.17
  11. Andrea N. Riner · 1 shared paper, 2022 · strength 0.17
  12. Yiping Li · 1 shared paper, 2022 · strength 0.17
  13. Jose Gilberto Trevino · 1 shared paper, 2022 · strength 0.17
  14. Shu-De Li · 2 shared papers, 2016 · strength 0.12
  15. Kaixuan Wang · 1 shared paper, 2021 · strength 0.12
  16. Hongwei Xu · 1 shared paper, 2021 · strength 0.12
  17. Yunliang Sun · 1 shared paper, 2016 · strength 0.07
  18. Jianxia Ma · 1 shared paper, 2016 · strength 0.07
  19. Zhaoshen Li · 1 shared paper, 2016 · strength 0.05
  20. Ping Li · 1 shared paper, 2016 · strength 0.05
  21. Gang Jin · 1 shared paper, 2016 · strength 0.05
  22. Jianqiang Liu · 1 shared paper, 2013 · strength 0.04
  23. Yiqi Du · 1 shared paper, 2013 · strength 0.04
  24. Zhaoshen Li · 1 shared paper, 2013 · strength 0.04
  25. Hui Chen · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.